The abstract and a digital PDF of each accepted poster will be included in the conference app for delegates to view on their smart devices.  Presenters must be present at the Welcome Reception on Monday evening to answer any questions from delegates during the function.

AO Poster Measurements:  841 mm wide x 1189 mm high, 33.1 inches wide x 46.8 inches high.  Full guidelines for poster submissions can be found be clicking here.

# TITLE ATTENDING AUTHORS
ACUTE KIDNEY INJURY
 01 GEMCITABINE INDUCED HEMOLYTIC URAEMIC SYNDROME SUCCESSFULLY TREATED WITH ECULIZUMAB – A CASE REPORT Muralikrishna Gangadharan Komala
 02 UNUSUAL PRESENTATION OF BILATERAL RENAL ARTERY STENOSIS AS ANURIC RENAL FAILURE WITH SUCCESSFUL STENTING Geoff Harley
 03 EPIDEMIOLOGY  AND COSTS OF MANAGEMENT OF ACUTE KIDNEY INJURY IN A TERTIARY CARE CENTER IN AUSTRALIA Sanjeeva  Herath
 04 SOFA COAGULATION SCORE AND PATIENT OUTCOMES IN SEVERE ACUTE KIDNEY INJURY: ANALYSIS FROM THE RANDOMISED EVALUATION OF NORMAL VERSUS AUGMENTED LEVEL (RENAL) STUDY Jin Lin
 05 RENAL CONSULT AUDIT AT A TERTIARY REFERRAL HOSPITAL Charlotte Ogilvy
 06 A CASE OF ACUTE KIDNEY INJURY AND THROMBOTIC MICROANGIOPATHY SECONDARY TO UROTHELIAL CANCER AND THE IMPACT OF TREATMENT ON THE DISEASE PROCESS Ben Talbot
 07 “UNEARTHING” THE CAUSE OF ACUTE KIDNEY INJURY IN A GARDENER Jeffrey Wong
 08 PATIENT-DERIVED ENDOTHELIAL CELL FUNCTION IS PREDICTED BY CONTROLLED BLOOD PRESSURE Brooke Huuskes
 09 RATES AND CHARACTERISTICS OF ACUTE KIDNEY INJURY (AKI) IN THE CHRONIC KIDNEY DISEASE IN QUEENSLAND (CKD.QLD) REGISTRY Gregory Wilson
 10 ETHYLENE GLYCOL TOXICITY – A RARE CAUSE OF HIGH ANION GAP METABOLIC ACIDOSIS IN AUSTRALIA Gregory Wilson
EPIDEMIOLOGY AND PUBLIC HEALTH
 11 ACUTE INTERSTITIAL NEPHRITIS (AIN) IN AUSTRALIA: A SINGLE CENTRE CASE SERIES Gregory Wilson
 12 TRAJECTORIES OF eGFR DECLINE OVER A FOUR YEAR PERIOD: THE eGFR FOLLOW UP STUDY Federica Barzi
 13 EVALUATING ASSOCIATIONS OF BODY MASS INDEX (BMI) IN CHRONIC KIDNEY DISEASE PATIENTS (CKD) IN THE CKD.QLD REGISTRY; QUEENSLAND, AUSTRALIA Samuel Chan
 14 DEATH FROM STROKE IN THE ESKD POPULATION; A COHORT STUDY IN AUSTRALIA AND NEW ZEALAND, 1980-2013 Nicole L De La Mata
 15 KNOWLEDGE ABOUT CHRONIC KIDNEY DISEASE IN THE AUSTRALIAN PUBLIC, USING A NEW VALIDATED QUESTIONNAIRE Pankti Gheewala
 16 ELDERLY DIALYSIS PATIENTS AND QUALITY OF LIFE: A SINGLE CENTRE EXPERIENCE Krystal Harrison
 17 DISTANCE TO HUB RENAL SERVICE AND OUTCOMES OF PATIENTS WITH STAGE IV-V CHRONIC KIDNEY DISEASE Prasanti Kotagiri
 18 KIDNEY DISEASE IN INCARCERATED TASMANIANS Stephanie Kuo
 19 ATTAINMENT OF HEMOGLOBIN, CALCIUM AND PHOSPHATE TARGETS, MORTALITY AND TIME TO TRANSPLANT IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS IN AUSTRALIA Dhanusya Sivanthanan
 20 RENAL MARKERS AT BASELINE IN THE HEALTHTRACK STUDY- A RANDOMISED CONTROL TRIAL OF INTERDISCIPLINARY CARE ON WEIGHT LOSS Maureen Lonergan
 21 SALT WASTING NEPHROPATHY(SWN) – IMPORTANT QUESTIONS Rishi Narenthiran
 22 SALT WASTING NEPHROPATHY(SWN) IN PRIMARY CARE Rishi Narenthiran
 23 THE PREVALENCE OF NON-DIABETIC PATHOLOGY IN THE RENAL BIOPSIES OF PATIENTS WITH DIABETES IN FAR NORTH QUEENSLAND Lee Skeat
 24 CHARACTERISTICS, MORTALITY AND RENAL OUTCOMES OF PATIENTS WITH DIABETES AND CKD WHO HAVE UNDERGONE RENAL BIOPSY. Samantha Ng
 25 A SINGLE CENTRE EXPERIENCE OF RENAL CALCULI IN CENTRAL AUSTRALIA Sajan Thomas
 26 THE PREVALENCE OF CHRONIC KIDNEY DISEASE AND ACUTE KIDNEY INJURY AMONGST ADULT ACUTE INPATIENTS AT MONASH HEALTH. Dan Tran
 27 CKD.QLD: RELATIONSHIP BETWEEN SMOKING AND CHRONIC KIDNEY DISEASE (CKD) IN THE DARLING DOWNS REGION, QUEENSLAND. Wendy Hoy
 28 PREVALENCE AND SEROCONVERSION OF HEPATITIS C VIRUS AMONG HEMODIALYSIS PATIENTS IN PEMALANG,INDONESIA Muchamad Nur Aziz
 29 APPROPRIATENESS OF NEPHROLOGY REFERRALS IN REGIONAL AUSTRALIA: IMPLICATIONS FOR A SPECIALIST SERVICE Rebecca Thwaites
 30 MEDICATION BURDEN, ADHERENCE AND HEALTH-RELATED QUALITY OF LIFE IN ADVANCED CHRONIC KIDNEY DISEASE Wubshet Tesfaye
CARDIOVASCULAR/HYPERTENSION
31 SUDDEN SEVERE HYPERTENSION: AN ATYPICAL MANIFESTATION OF PRIMARY HYERPARATHYROIDISM. A CASE REPORT Claudia Ferrier
32 RENAL ARTERY STENOSIS AS A CAUSE OF TAKOTSUBO CARDIOMYOPATHY Victoria Sasongko
33 FIRST CARDIOVASCULAR EVENT POST ENROLMENT IN CKD.QLD REGISTRY PATIENTS WITH DIABETES WHO HAVE UNDERGONE RENAL BIOPSY Ken-soon Tan
34 HIGH-SENSITIVITY CARDIAC TROPONIN T AND C-REACTIVE PROTEIN HAVE DIFFERENT PROGNOSTIC VALUES IN HAEMO- AND PERITONEAL DIALYSIS POPULATION: A COHORT STUDY Titi Chen
GLOMERULONEPHRITIS
35 RENAL CD141+ DENDRITIC CELLS INFILTRATION IN CRESCENTIC GLOMERULONEPHRITIS IN HUMAN AND MICE Padmashree Rao
36 RENAL CD141+ DENDRITIC CELL INFILTRATION IN IGA NEPHROPATHY Padmashree Rao
37 COMPLICATED ATRIAL THROMBUS IN RENAL TRANSPLANT RECIPIENT WITH RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) Nyi Aung
38 PREVALENCE OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE IN PATIENTS UNDERGOING DIAGNOSTIC RENAL BIOPSY Ke Li Chow
39 A CASE REPORT OF HENOCH-SCHONLEIN PURPURA AND IGA NEPHROPATHY ASSOCIATED WITH RIVAROXABAN Edmund Chung
40 A CASE OF ANTI-GBM BEHAVING DIFFERENTLY Sanduni Fernando
41 A CASE OF METHAMPHETAMINE-RELATED IMMUNE COMPLEX GLOMERULONEPHRITIS WITH INTENSE INTERSTITIAL INFLAMMATION Sarah Gleeson
42 OTITIS MEDIA WITH ANCA – ASSOCIATED VASCULITIS: A CASE FROM TASMANIA Alison Graver
43 CLINICAL AUDIT OF HISTOLOGY BASED RENAL DISEASES IN DARLING DOWNS HEALTH REGION Vinod Khelgi
44 MEMBRANOUS NEPHROPATHY AND MALIGNANCY-A REPORT FROM DARLING DOWNS HOSPITAL AND HEALTH SERVICE Vinod Khelgi
45 PREVALENCE OF ANCA VASCULITIS IN DDHHS POPULATION Vinod Khelgi
46 THE MAN WHO ‘CRIED’ WOLF: CRYOGLOBULINEMIC GLOMERULONEPHRITIS ASSOCIATED WITH T CELL LYMPHOMA Jennifer Li
47 PARANEOPLASTIC IMMUNOGLOBULIN A NEPHROPATHY AND ASSOCIATED FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN ASYMPTOMATIC LOW VOLUME B-CELL LYMPHOMA Andrew Mallett
48 C1Q DEPOSITION IN A CASE SERIES OF CHILDREN WITH HENOCH-SCHÖNLEIN PURPURA AND POSITIVE STREPTOCOCCAL SEROLOGY Ashlene Mckay
49 JEJUNAL ULCERATION DUE TO GRANULOMATOSIS WITH POLYANGITIS Daniela Potter
50 ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE AND THE EYE Daniela Potter
51 IgA-MEDIATED ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE Amanda Siriwardana
52 A RETROSPECTIVE ANALYSIS OF LUPUS NEPHRITIS IN THE INDIGENOUS AND NON-INDIGENOUS POPULATIONS IN THE NORTHERN TERRITORY: TREATMENT, OUTCOMES AND CHALLENGES Priyanka Subramani
53 WARFARIN VS NEW ORAL ANTICOAGULANT IN PRIMARY ADULT NEPHROTIC SYNDORME ASSOCIATED VENOUS THORMBOEMBOLISM Zaw Thet
54 HAEM PIGMENT-INDUCED CHRONIC KIDNEY DISEASE IN A PATIENT WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY Marina Wainstein
55 ACUTE POST-STREPTOCOCCAL GLOMERULONEPHRITIS- A CASE REPORT AND EPIDEMIOLOGICAL DATA FROM THE NORTHERN TERRITORY OF AUSTRALIA Swasti Chaturvedi
56 SYSTEMIC LUPUS ERYTHEMATOSUS MASQUERADING AS ATYPICAL HAEMOLYTIC URAEMIC SYNDROME Stephanie Kuo
57 PULMONARY FIBROSIS IN RENAL ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) ASSOCIATED VASCULITIS IN TASMANIA OVER A 10 YEAR PERIOD Stephanie Kuo
HEALTH SERVICES RESEARCH
58 MANAGEMENT OF MEDICATIONS IN PEOPLE WITH CHRONIC KIDNEY DISEASE Stephanie Kuo, Alison Graver
59 ADVANCED CARE PLANNING IN END-STAGE KIDNEY DISEASE – WE CAN DO BETTER Margaret Fraenkel
60 ANALYSIS OF LONGITUDINAL CLINICAL DATA TO EVALUATE CHANGES IN THE SCREENING FOR AND MANAGEMENT OF CKD IN SELECT NT PRIMARY HEALTH SERVICES. Gillian Gorham
61 CHRONIC KIDNEY DISEASE (CKD) AND HEALTH CARE UTILISATION: INSIGHTS FROM HEALTH DATA LINKAGE IN QUEENSLAND Wendy Hoy
62 PRELIMINARY RESULTS OF AN ECONOMIC EVALUATION OF RESONIUM USE IN ADULTS WITH CHRONIC HYPERKALEMIA Kelly Lambert
63 DO NORTHERN TERRITORY PATIENTS GET HOME? ANALYSIS THROUGH THE DIALYSIS MODELS OF CARE PARTNERSHIP Paul Lawton
64 DEVELOPING AN IMPROVED MODEL OF CARE FOR RENAL OUTPATIENTS IN THE NORTHERN TERRITORY (NT) Kelum Priyadarshana
GENERAL NEPHROLOGY – OTHER
65 RENAL AMYLOIDOSIS: IT’S NOT ALL AL Emily Butler
66 CHRONIC USE OF SODIUM POLYSTYRENE SULFONATE (RESONIUM) ENABLES WIDER IMPLEMENTATION OF RENIN-ANGIOTENSIN-ALDOSTERONE INHIBITION IN CHRONIC KIDNEY DISEASE PATIENTS Kelly Lambert
67 LIRAGLUTIDE FACILITATES INSULIN MINIMISATION AND WEIGHT LOSS IN PATIENTS WITH ADVANCED KIDNEY DISEASE Jamie Cheong
68 EFFICACY AND SAFETY OF A MEMBRANE BASED REGIONAL CITRATE ANTICOAGULATION PLASMA EXCHANGE PROTOCOL: AN OBSERVATIONAL, PROSPECTIVE, SINGLE CENTER STUDY Daniel Christiadi
69 PRE-OPERATIVE EGFR AND LENGTH OF POST-OPERATIVE HOSPITALISATION IN TUMOUR NEPHRECTOMY PATIENTS Robert Ellis
70 THE UPS AND DOWNS OF BARIATRIC SURGERY: A CASE OF REVERSIBLE OXALATE NEPHROPATHY Alexandra Gallagher
71 AN AUDIT OF RENAL BIOPSY COMPLICATIONS Alison Graver
72 HEPCIDIN RESPONSE TO IV IRON IS DIFFERENT IN CHRONIC KIDNEY DISEASE PATIENTS COMPARED WITH PREGNANCY AND HEALTHY CONTROLS Louis Huang
73 DENOSUMAB INDUCED HYPOCALCAEMIA IN CHRONIC KIDNEY DISEASE (CKD): PREVENTION IS BETTER THAN TREATMENT Ryan Jalleh
74 CASE SERIES OF CALCIPHYLAXIS AT DDHHS: SINGLE CENTRE EXPERIENCE Vinod Khelgi
75 SEROCONVERSION RATES OF HEPATITIS B IN CHRONIC KIDNEY DISEASE AND DIALYSIS COHORTS- A SINGLE CENTRE OBSERVATIONAL STUDY. Ashani Lecamwasam
76 DNA METHYLATION PROFILING OF GENOMIC DNA ISOLATED FROM URINE IN DIABETIC CHRONIC KIDNEY DISEASE: A PILOT STUDY Ashani Lecamwasam
77 ENDOTHELIAL GLYCOCALYX DAMAGE IN KIDNEY DISEASE CORRELATES WITH MARKERS OF ENDOTHELIAL DYSFUNCTION Hui Liew
78 ACUTE RENAL FAILURE, RASH AND DIFFUSE PROLIFERATIVE GLOMERULONEPHRITIS FOLLOWING THREE DOSES OF ETANERCEPT FOR RHEUMATOID ARTHRITIS Maureen Lonergan
79 A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE USEFULNESS OF GLYCATED HAEMOGLOBIN (HBA1C) AND GLYCATED ALBUMIN AS MEASURES OF BLOOD GLUCOSE LEVELS IN PEOPLE WITH ON DIALYSIS Sandawana William Majoni
80 RELATIVE VALIDITY OF A BEVERAGE FREQUENCY QUESTIONNAIRE TO ESTIMATE FLUID INTAKE IN CHRONIC KIDNEY DISEASE. Carly Mannix
81 UNPROVOKED PULMONARY EMBOLISM IN A RENAL TRANSPLANT PATIENT WITH BETA THALASSAEMIA MAJOR Cathal McGowan
82 COMPLEXITIES OF SYMPTOM MANAGEMENT AND PROGNOSTICATION IN A CASE OF CONSERVATIVELY MANAGED END-STAGE KIDNEY DISEASE (ESKD) Simon Olenski
83 ESTABLISHING A CHRONIC KIDNEY DISEASE BIOBANK IN QUEENSLAND TO SUPPORT FUTURE RESEARCH Evan Owens
84 THE DISTINGUISHING RISK OF PROGRESSIVE CHRONIC KIDNEY DISEASE (DROP CKD) STUDY Evan Owens
85 A CASE OF EVOLVING LUPUS PRESENTING AS REFRACTORY THROMBOTIC MICROANGIOPATHY Theepika Rajkumar
86 OBSERVATIONAL CROSS SECTIONAL STUDY INVESTIGATING THE PREVALENCE OF FABRY DISEASE IN CHRONIC STABLE DIALYSIS POPULATION (FIDS). Gowri Raman
87 THE DIAGNOSIS AND MANAGEMENT OF TAKAYASU’S ARTERITIS IN A REGIONAL SETTING Joey Lam
88 EVALUATION OF PAIN IN RENAL INTERVENTIONS Victoria Sasongko
89 HEALTH LITERACY IN A SINGLE SITE RENAL SUPPORTIVE CARE CLINIC Jessica Stevenson
90 SEVERE HYPONATRAEMIA, BEER POTOMANIA AND RHABDOMYOLYSIS Robert Stonehouse
91 UPDATE ON HOW TELEHEALTH REVOLUTIONISED RENAL HEALTHCARE DELIVERY IN WAIKATO HOSPITAL, NEW ZEALAND Eddie Tan, Theresa Jennings
92 RENAL TUBERCULOSIS AFTER INTRAVESCIAL BACILLE CALMETTE- GUERIN (BCG) IMMUNOTHERAPY  Zaw Thet
93 INTERIM ANALYSIS OF FABRY TESTING IN WESTERN AUSTRALIA RENAL DIALYSIS PATIENTS: THE FoRWARD STUDY Shamina Akhter
94 DIABETIC MYONECROSIS IN DIABETIC KIDNEY DISEASE Nicholas Trott
95 “INTERVENTIONAL DAY UNIT” – A SOUTH WESTERN SYDNEY LOCAL HEALTH DISTRICT (SWSLHD) OUTPATIENT SERVICE INITIATIVE. REDESIGNING RENAL SERVICE DELIVERY Jeff Wong
96 THE USUAL DIET OF AN AUSTRALIAN POPULATION OF ADPKD PATIENTS Jennifer Zhang
97 INFLUENCE OF TIMING AND PATIENT CHARACTERISTICS ON OUTCOMES OF A COMPREHENSIVE PRE-DIALYSIS PROGRAMME IN WESTERN SYDNEY Lukas Kairaitis
98 TOTAL NEPHRON NUMBER DECREASES WITH THE STAGE OF CHRONIC KIDNEY DISEASE – A STUDY IN JAPANESE SUBJECTS Go Kanzaki
99 CHARACTERISTICS OF THE SCREENED STUDY POPULATION IN THE PREVENT-ADPKD TRIAL Annette Wong
HAEMODIALYSIS – CKD-MBD/ANAEMIA/ADEQUACY
100 INDIVIDUALISED FLUID ALLOWANCE CALCULATOR FOR HAEMODIALYSIS PATIENTS Shi Zhou Choo
101 BROWN TUMOURS MANIFESTING AS MULTIPLE LYTIC LESIONS IN A GENTLEMAN ON DIALYSIS WITH LONGSTANDING UNCONTROLLED HYPERPARATHYROIDISM Geoff Harley
102 IS THE EFFICACY OF NUTRITIONAL VITAMIN D (CHOLECALCIFEROL) COMPARABLE TO ACTIVE VITAMIN D (CALCITRIOL) AS MAINTENANCE THERAPY IN DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS? Chau Wang Ng
103 MARKED REDUCTION IN USE BUT MINIMAL IMPACT FOLLOWING PBS DELISTING OF CINACALCET IN A TERTIARY INSTITUTION Yogeshwar Rajaram
104 RETROSPECTIVE OBSERVATIONAL STUDY COMPARING TWO ANAEMIA MANAGEMENT PROTOCOLS FOR PATIENTS ON MAINTENANCE HAEMODIALYSIS David Langsford
HAEMODIALYSIS – OTHER
105 ELECTROCARDIOGRAPHY (ECG) AND OUTCOME IN PATIENTS ON MAINTENANCE HAEMODIALYSIS Tony Amin
106 THE VICTORIAN GREENS SURVEY: GAUGING RESPONSES TO ENVIRONMENTAL EFFICIENCIES IN NEPHROLOGY SERVICES Katherine Barraclough
107 SUCCESSFUL CALCIPHYLAXIS TREATMENT WITH PARENTERAL VITAMIN K Daniel Christiadi
108 PREVALENCE OF MALNUTRITION AMONGST HAEMODIALYSIS PATIENTS ATTENDING NIGHTCLIFF RENAL UNIT Christine Cooper
109 EVALUATION OF NUTRITION RESOURCES TARGETED AT AN INDIGENOUS AUDIENCE Camilla Feeney
110 COMPARING BIOIMPEDENCE SPECTROSCOPY FLUID BALANCE ASSESSMENT TO CLINICAL FLUID BALANCE ASSESSMENT IN HAEMODIALYSIS PATIENTS Sarah Gleeson
111 LOW RATES OF HEPATITIS B IMMUNITY IN CENTRE HAEMODIALYSIS PATIENTS Hilton Gock
112 DELAYED RESOLUTION OF AN EXTENSIVE DERMATOPHYTE INFECTION: CLIENT AND CLINICIAN PERCEPTIONS OF TREATMENT RESPONSE IN AN ADULT DEPENDENT ON HAEMODIALYSIS Jaquelyne Hughes
113 CHARACTERISTICS OF CLIENTS AT INCIDENT HAEMODIALYSIS TREATMENT: A RETROSPECTIVE AUDIT IN A NORTHERN AUSTRALIAN HOSPITAL Jaquelyne Hughes
114 THE EFFECT OF INTENSIFIED HOME HAEMODIALYSIS TRAINING: A SINGLE CENTRE EXPERIENCE Graham Stonier, Eddie Tan
115 A LOCAL EXPERIENCE OF HOW TELEHEALTH REVOLUTIONISED THE ROLE OF RURAL RENAL NURSING Theresa Jennings, Eddie Tan
116 A SINGLE-CENTRE 12-MONTH RETROSPECTIVE AUDIT OF SATELLITE HAEMODIALYSIS PATIENT ATTENDANCE AND UNUSUED SLOTS Theresa Jennings
117 THE STANDARDISED OUTCOMES IN NEPHROLOGY-HAEMODIALYSIS (SONG-HD) CONSENSUS WORKSHOP ON ESTABLISHING A CORE OUTCOME MEASURE FOR FATIGUE IN PATIENTS ON HAEMODIALYSIS Angela Ju
118 IS THERE ANY BENEFIT OF SEASONAL INFLUENZA VACCINATION IN DIALYSIS POPULATION ? Jola Kapojos
119 ZINC DEFICIENCY AND ASSOCIATED FACTORS IN A COHORT OF HAEMODIALYSIS PATIENTS Jocelyn King
120 ASSISTED SELF-CARE HAEMODIALYSIS COMPARED TO IN-CENTRE HAEMODIALYSIS – A SINGLE CENTRE EXPERIENCE Jason Lee
121 THE SYNDROME OF ACUTE BILATERAL BASAL GANGLIA DYSFUNCTION IN DIALYSIS PATIENTS – RISK FACTORS, PRESENTATION AND OUTCOMES Revathy Manickavasagar
122 “A CHANGE OF HEART”: A CASE SERIES ANALYSIS OF END STAGE KIDNEY DISEASE PATIENTS CHANGING FROM CONSERVATIVE TO ACTIVE DIALYSIS TREATMENT. Katherine Nguyen
123 PNEUMATIC COMPRESSION DEVICES IN THE PREVENTION OF INTRADIALYTIC HYPOTENSION Huan Dang, Christopher Sia
124 IS DIABETIC MYONECROSIS MORE COMMON THAN WE THOUGHT? A CLUSTER OF CASES IN PATIENTS WITH END STAGE KIDNEY DISEASE IN CENTRAL AUSTRALIA Priyanka Subramani
125 HIGH-DOSE INTRAVENOUS METHOTREXATE WITH HIGH-FLUX HAEMODIALYSIS IN TREATMENT OF POST-TRANSPLANT, CENTRAL NERVOUS SYSTEM LYMPHOMA WITH END-STAGE KIDNEY DISEASE Erin Vaughan
126 AN UNUSUAL CASE OF HYPERCALCAEMIA IN A HAEMODIALYSIS PATIENT Catherine Wilkinson
127 CONTACT PRECAUTIONS FOR COLONISATION WITH MULTI-DRUG REISTANT ORGANISMS AND HAEMODIALYSIS PATIENT QUALITY OF LIFE AND MOOD: A PILOT CASE CONTROL STUDY Catherine Wilkinson
128 GASTROINTESTINAL SYMPTOMS IN PATIENTS RECEIVING DIALYSIS: A SYSTEMATIC REVIEW Jordan Zuvela
HAEMODIALYSIS   VASCULAR ACCESS
129 CLINICAL OUTCOMES OF PERCUTANEOUS THROMBECTOMY OF DIALYSIS ACCESS THROMBOSIS BY NEPHROLOGISTS IN CENTRAL AUSTRALIA David Kiran Fernandes
130 REPORTING FEASIBILITY OF THE USE OF A REAL-TIME DATA REPORTING TOOL TO IMPROVE OUTCOMES OF HAEMODIALYSIS CATHETER COMPLICATIONS ACROSS AUSTRALIA (REDUCCTION) Sradha Kotwal
131 REVIEW OF ANTI-MICROBIAL RESISTANT ORGANISMS CAUSING VASCULAR ACCESS ASSOCIATED BACTERAEMIA IN HAEMODIALYSIS PATIENTS IN 2015-2016 Laila Parvaresh
132 USE OF A CLINICAL SCORING TOOL IN PREDICTING ARTERIOVENOUS FISTULAS LIKELY TO FAIL TO MATURE Tahira Scott
133 ROLE OF SERUM GENTAMICIN LEVEL TESTING IN HAEMODIALYSIS PATIENTS RECEIVING GENTAMICIN LOCKS FOR TUNNELED VENOUS CATHETERS Jacqueline Soraru
134 OMEGA-3 PUFA SUPPLEMENTATION TO PREVENT ARTERIOVENOUS FISTULA AND GRAFT FAILURE: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS Andrea Viecelli
135 VASCULAR ACCESS IN PATIENTS COMMENCING HAEMODIALYSIS – RESULTS OF IMPLEMENTATION OF A QUALITY IMPROVEMENT PROJECT Tamara Young
PAEDIATRICS
136 THE MULTIDISCIPLINARY PAEDIATRIC RENAL GENETICS CLINIC: A MODEL FOR MAINSTREAMING GENETICS IN MEDICINE  Andrew Mallett
PERITONEAL DIALYSIS
137 CULTURE-INDEPENDENT IDENTIFICATION OF BACTERIA CAUSING PERITONEAL DIALYSIS ASSOCIATED PERITONITIS Aron Chakera
138 DEVELOPING AN ASSISTED AUTOMATED PERITONEAL DIALYSIS PROGRAM IN WESTERN AUSTRALIA Aron Chakera
139 RAPID ASSESSMENT OF BACTERIAL LOAD AND RESISTANCE PHENOTYPE IN PERITONEAL DIALYSIS EFFLUENT BY FLOW CYTOMETRY Aron Chakera
140 AN UNUSUAL CASE OF CATHETER MIGRATION IN A PERITONEAL DIALYSIS PATIENT Shyamalee Crocker
141 USE OF DEFERASIROX (EXJADE) FOR IRON OVERLOAD IN PERITONEAL DIALYSIS PATIENTS. Erwin Yii
142 CLOUDY BAG: NOT ALWAYS PERITONITIS Vinod Khelgi
143 MORGANELLA MORGANII PD-RELATED PERITONITIS IN A LUNG TRANSPLANT PATIENT Alice Lee
144 PERITONEAL DIALYSIS CATHETERS FOR RECURRENT/REFRACTORY ASCITES DRAINAGE Eddie Tan
145 RETAINED PERITONEAL DIALYSIS CATHETER TUNNELING DEVICE SEGMENT ASSOCIATED WITH RECURRENT PERITONITIS: A CASE REPORT Beata Zahorowska
146 GASTROINTESTINAL MUCORMYCOSIS IN A PERITONEAL DIALYSIS PATIENT WITH END STAGE RENAL FAILURE SECONDARY TO AA AMYLOIDOSIS: A CASE REPORT Beata Zahorowska
TRANSPLANTATION
147 DETECTION OF HEPATITIS C ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS FROM A DECEASED DONOR PREVIOUSLY TREATED FOR HEPATITIS C Neeru Agarwal
148 A RETROSPECTIVE STUDY OF DONOR NEPHRECTOMY ON RENAL FUNCTION AND APPLICATION OF LIVING KIDNEY DONOR PROFILE INDEX (LKDPI) Nyi Aung
149 FLUDROCORTISONE IN THE MANAGEMENT OF TUBULOPATHIES POST-RENAL TRANSPLANTATION Shyamalee Crocker
150 THROMBOLYSIS FOR PULMONARY EMBOLISM EARLY POST-RENAL TRANSPLANTATION Shyamalee Crocker
151 COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY USE IN END STAGE RENAL FAILURE Sarah Gleeson
152 THE SYMPTOM BURDEN OF TRANSPLANT PATIENTS COMPARED TO DIALYSIS PATIENTS Jeffrey Ha
153 EXPECTATIONS AND EXPERIENCES OF FOLLOW UP AND SELF-CARE AFTER LIVING KIDNEY DONATION: A FOCUS GROUP STUDY Camilla Hanson
154 EARLY GRAFT LOSS DUE TO RECURRENCE OF DIABETIC NEPHROPATHY FOLLOWING LIVE DONOR KIDNEY TRANSPLANTATION Jack Heron
155 BACILLARY ANGIOMATOSIS IN A RENAL TRANSPLANT RECIPIENT Vinod Khelgi
156 NON-ABO RED BLOOD CELL GROUP ANTIGENS IN RENAL TRANSPLANTATION Prasanti Kotagiri
157 THE ADOPT TRIAL: A PHARMACOMETRIC STUDY OF THE BETWEEN-OCCASION VARIABILITY IN FREE MYCOPHENOLIC ACID PHARMACOKINETICS PRIOR TO AND IN THE EARLY PHASE POST KIDNEY TRANSPLANT IN SIXTY PROSPECTIVELY RECRUITED ADULTS AND CHILDREN David Metz
158 RHABDOMYOLYSIS SECONDARY TO SEASONAL INFLUENZA VACCINE IN A RENAL TRANSPLANT RECIPIENT Amanda Siriwardana
159 SCEDOSPORIUM APIOSPERMUM BONE INFECTION IN A RENAL TRANSPLANT RECIPIENT Amanda Siriwardana
160 RESISTANT CYTOMEGALOVIRUS DISEASE IN KIDNEY-PANCREAS TRANSPLANT: TREATMENT WITH PRIMED T-CELL THERAPY Sarah So
161 SPONTANEOUS ATRAUMATIC SPLENIC RUPTURE FOLLOWING INTRAVENOUS IMMUNOGLOBULIN FOR PARVOVIRUS B19 ASSOCIATED PURE RED CELL APLASIA IN A RENAL TRANSPLANT PATIENT – A CASE REPORT Mark Tiong
162 POST RENAL TRANSPLANT EXTRAPULMONARY TUBERCULOSIS IN AN OVERSEAS-BORN AUSTRALIAN Catherine Wilkinson
163 TEMPORAL TRENDS IN CLINICAL OUTCOMES OF KIDNEY TRANSPLANTATION FROM 1996 TO 2013 IN AUSTRALIA AND NEW ZEALAND Wing Chi Gigi Yeung
164 CORRELATION AND AGREEMENT BETWEEN THE NUMBER OF CLASS I AND II EPLET MISMATCHES CALCULATED USING SEROLOGICAL, LOW-INTERMEDIATE AND HIGH RESOLUTION MOLECULAR HUMAN LEUKOCYTE ANTIGEN TYPING METHODS Wai Lim
165 MORTALITY FOLLOWING PRIMARY RENAL ALLOGRAFT FAILURE – A REGISTRY ANALYSIS Wai Lim

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the conference.
/wp-content/uploads/2017/08/Conference-Design-400x400.png
© 2015 - 2016 Conference Design Pty Ltd